Previous evidence documented that BPA exposure stimulated SREBP1 and its downstream enzymes involved in lipogenesis, and eventually caused dyslipidemia, fat accumulation and NAFLD (29). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.